LOADING
Comparing Thermo Fisher Scientific (TMO) and Cisco Systems (CSCO) across the Health Care and Technology sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | TMO | CSCO |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $242.1B | $442.4B |
| P/E Ratio | 35.2 | 33.7 |
| Forward P/E | 24.1 | 19.8 |
| PEG Ratio | 1.98 | 0.98 |
| EPS | $18.60 | $3.33 |
| Revenue Growth (YoY) | 10.5% | 17.6% |
| Profit Margin | 15.0% | 20.9% |
| Return on Equity | 13.5% | 27.3% |
| Dividend Yield | 0.28% | 1.53% |
| Beta | 0.85 | 0.99 |
| 52-Week High | $683.63 | $129.38 |
| 52-Week Low | $434.50 | $65.60 |
| Volume | -- | -- |
Cisco Systems is the larger company by market capitalization. Cisco Systems trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Cisco Systems offers a higher dividend yield for income investors. Cisco Systems has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.